International variation in the use of evidence-based medicines for acute coronary syndromes

来自 EBSCO

阅读量:

38

摘要:

AIMS: We sought to evaluate international patterns of use and factors influencing use of evidence-based medications early after .: Using a database of 15904 ACS patients enrolled in the SYMPHONY and 2nd SYMPHONY trials in 37 countries, we performed descriptive and logistic regression analyses. After controlling for other factors, region was significantly associated with the use of every class of evidence-based medication, most pronounced for intravenous unfractionated (IV UFH), low-molecular-weight (LMWH), II converting enzyme inhibitors () and discharge use of -lowering agents. Latin America and Eastern Europe were among the highest users of early , yet the lowest users of discharge -lowering therapy. Relative to the United States, all regions except Canada had greater use of LMWH and lower use of IV UFH. Compared with patients with , those with less often received aspirin, beta-blockers, , or IV UFH. Older age was associated with lower use of aspirin, beta-blockers, IV UFH, and -lowering agents.: Use of evidence-based therapies for management of patients is strongly associated with region. To improve patient outcomes, more research is needed to understand this variation, and to institute appropriate solutions.

展开

DOI:

10.1016/j.ehj.2003.09.018

被引量:

159

年份:

2003

通过文献互助平台发起求助,成功后即可免费获取论文全文。

我们已与文献出版商建立了直接购买合作。

你可以通过身份认证进行实名认证,认证成功后本次下载的费用将由您所在的图书馆支付

您可以直接购买此文献,1~5分钟即可下载全文,部分资源由于网络原因可能需要更长时间,请您耐心等待哦~

身份认证 全文购买

相似文献

参考文献

引证文献

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用